| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.097 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |